The consequences of this out-of-whack market are felt by taxpayers and American families every time they pick up a prescription at the pharmacy counter.
Ron Wyden
The Public Record
Ron Wyden is an American politician serving as the senior United States senator from Oregon, a position he has held since 1996. A member of the Democratic Party, Wyden has been a prominent advocate for civil liberties, healthcare reform, and technology policy. Throughout his tenure, he has focused on issues such as privacy rights, government surveillance, and access to healthcare, often emphasizing the importance of transparency and accountability in government actions.
My simple message is this: every drug should have a price that is available for all to see and creates equity.
I think your answer is spot-on, and I would be interested in any information you have or could supply.
The Pharmacy Benefit Manager Transparency Act of 2023 would make material improvements to the transparency of the U.S. health-care system.
That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers and patients aren't getting a raw deal.
In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the health-care system in this country.
I am leading a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would crack down on PBM's opaque rebate practices.
Our bipartisan efforts on organ transplants--thank you very much, Senator Grassley--have really paid off.
Today's hearing is an important opportunity for committee members to get up to speed on the latest practices being employed by pharmacy benefit managers and the impact these tactics are having on taxpayers and Americans who count on…
What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?
I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.
I'm proud to say that this is a hearing with strong bipartisan interest, and Senator Crapo and I have agreed to take on this issue together.
NACDS applauds Chairman Wyden and Ranking Member Crapo for keeping this issue top of mind on a bipartisan basis.
Senator Cardin has been after these issues for years and years, before they became popular.
Deamonte Driver was a 12-year-old who lived in Prince George's County, MD, about 7 miles from here.
Senator Moynihan always stood for the proposition that a big part of the job in intelligence is striking the balance between transparency and protecting sources and methods.
The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.
You always know whose side Senator Brown is on. Senator Brown is always on the side of the working families and the senior citizens.
I think your answer is spot-on, and I would be interested in any information you have or could supply.
Deamonte Driver was a 12-year-old who lived in Prince George's County, MD, about 7 miles from here.
Disparities in our health-care system are well documented, and the impact they have in regard to vulnerable communities.
One of the reasons is that there are too many secrets of matters that do not need to be secret.





